40 results on '"Kaku, Yu"'
Search Results
2. Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case
3. Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236
4. Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility
5. Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236
6. Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1
7. Virological characteristics of the SARS-CoV-2 JN.1 variant
8. Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals
9. Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG
10. Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5
11. Idiotopes of antibodies against HIV‐1 CD4‐induced epitope shared with those against microorganisms.
12. Addition of maraviroc to antiretroviral therapy decreased interferon-γ mRNA in the CD4+ T cells of patients with suboptimal CD4+ T-cell recovery
13. Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility
14. Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC
15. Virological characteristics of the SARS-CoV-2 XEC variant
16. Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant
17. Development and characterization of a panel of anti-idiotype antibodies to 1C10 that cross-neutralize HIV-1 subtype B viruses
18. Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants
19. Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution
20. Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19
21. Additional file 8 of Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG
22. Additional file 10 of Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG
23. Additional file 2 of Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG
24. Additional file 9 of Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG
25. Additional file 4 of Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG
26. Additional file 5 of Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG
27. Additional file 7 of Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG
28. Additional file 6 of Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG
29. Additional file 3 of Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG
30. Functional analysis of a monoclonal antibody reactive against anti-cluster A epitope obtained from a patient infected with HIV-1 CRF02_AG
31. Prediction of Contact Residues in Anti-HIV Neutralizing Antibody by Deep Learning
32. Clinical study of giant cell arteritis in our hospital
33. Corticoid Therapy for Overlapping Syndromes in an HIV-positive Patient
34. The Usefulness of the Scan with 67Ga-citrate to Assess the Therapeutic Effect on Pneumocystis pneumonia with HIV-1 Infection
35. Synthesis of a Rhodamine-Appended Cyclophane as a Fluorescence Host in Water
36. Synthesis of Dabsyl-Appended Cyclophanes and Their Heterodimer Formation with Pyrene-Appended Cyclophanes
37. Synthesis and Enhanced Guest-Binding Affinities of Dendrimer-Based Cyclophane Tetramer and Octamer
38. Virological characteristics of the SARS-CoV-2 LP.8.1 variant.
39. Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility.
40. Clinical study of giant cell arteritis in our hospital.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.